OCTREOTIDE
octreotide 30 mg modified release injection [1 vial] (&) inert substance diluent [2
mL syringe], 1 pack
OCTREOTIDE (11893Y)
11893Y
Manner of administration:Injection
Restriction (Streamlined authority code: 17635)
Indication: Non-functional gastroenteropancreatic neuroendocrine tumour (GEP-NET)
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 2 | # of repeats: 5 | DPMQ: $1,207.32 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Sandostatin LAR | |||||